Lilly and NVIDIA Invest $1B in AI-Driven Drug Discovery
SAN FRANCISCO, January 12, 2026 — NVIDIA and Eli Lilly and Company announced the creation of a first-of-its-kind AI...
Drug Discovery
Advertisement
Junevity Study Reveals Single-Target Control of Cellular Aging
BOSTON, Massachusetts — January 12, 2026 — Junevity has announced the publication of its first peer-reviewed scientific study demonstrating...
DISCO–Amgen License Deal Advances Surfaceome Cancer Therapies
COLOGNE, Germany – January 7, 2026 — DISCO Pharmaceuticals has entered into an exclusive global license agreement with Amgen...
Excelsior Sciences Raises $95M to Advance Machine-Enabled Chemistry for Faster Drug Discovery
San Francisco, CA – December 3, 2025 — Excelsior Sciences has raised $95 million in new funding to accelerate...
IonQ & CCRM Forge Quantum-Biotech Alliance to Transform Therapeutics
College Park, MD, December 1, 2025 — IonQ has announced a strategic partnership with CCRM to accelerate the development...
Advertisements
AEON Biopharma Posts Q3 Gains with Strong ABP-450 Biosimilarity Data
IRVINE, CA — November 14, 2025 — AEON Biopharma announced its third-quarter 2025 financial results, highlighting strong operational progress,...
Gate Bioscience Raises $65M to Advance Molecular Gates
BRISBANE, CA – November 13, 2025 — Gate Bioscience announced the closing of an oversubscribed $65 million Series B...
Novartis Expands RNA Therapeutics Portfolio with Avidity Acquisition
Basel, Switzerland – October 26, 2025: Novartis AG announced its agreement to acquire Avidity Biosciences, a U.S. biotechnology company...
Swiss Rockets Partners with Squirro to Transform AI in Biotech
Basel, Switzerland – October 23, 2025: Swiss Rockets AG has announced a strategic partnership with Squirro AG aimed at...
Advertisement
